Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes, and spinal muscular atrophy.

Drugs are usually tested in animal models, but using animals for research is expensive and may raise ethical concerns. Additionally, animal models may not accurately mirror human physiology or the disease under investigation. Patient-derived iPSCs have the same genetic makeup as the patient’s disease-affected cells. When differentiated, these cells can replicate the physiology of the diseased tissue and show a nearly accurate disease phenotype.

Drugs for treating cardiovascular, neurodegenerative, and liver disorders are currently being tested using cells derived from iPSCs. The cells are used to screen drugs for their effects and possible toxicity at varying doses. This can be part of a pre-clinical study of a medicine before it is tested directly in humans in clinical trials.

Tags
Embryonic Stem CellsInduced Pluripotent Stem CellsIPSCsDisease ResearchCell DifferentiationDisease ModelsDown SyndromeType I DiabetesSpinal Muscular AtrophyPatient derived IPSCsDrug TestingPre clinical StudyHuman PhysiologyDisease Phenotype

Do Capítulo 43:

article

Now Playing

43.8 : Células EPS e iPS na Pesquisa de Doenças

Células-Tronco Pluripotentes Embrionárias e Induzidas

2.7K Visualizações

article

43.1 : Células-Tronco Embrionárias

Células-Tronco Pluripotentes Embrionárias e Induzidas

3.2K Visualizações

article

43.2 : Manutenção do Estado da Célula ES

Células-Tronco Pluripotentes Embrionárias e Induzidas

2.1K Visualizações

article

43.3 : Células-Tronco Pluripotentes Induzidas

Células-Tronco Pluripotentes Embrionárias e Induzidas

3.7K Visualizações

article

43.4 : Reprogramação de Células Somáticas para iPS

Células-Tronco Pluripotentes Embrionárias e Induzidas

2.1K Visualizações

article

43.5 : Modificação de Cromatina em Células iPS

Células-Tronco Pluripotentes Embrionárias e Induzidas

1.6K Visualizações

article

43.6 : Diferenciação de Células iPS

Células-Tronco Pluripotentes Embrionárias e Induzidas

2.6K Visualizações

article

43.7 : Transdiferenciação Forçada

Células-Tronco Pluripotentes Embrionárias e Induzidas

1.8K Visualizações

JoVE Logo

Privacidade

Termos de uso

Políticas

Pesquisa

Educação

SOBRE A JoVE

Copyright © 2025 MyJoVE Corporation. Todos os direitos reservados